U.S. FDA approves Celltrion's OMLYCLO ® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR ®

8 months ago 27

1. Homepage
2. Finance
3. U.S. FDA approves Celltrion's OMLYCLO ® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR ®